Sultamicillin CAS 76497-13-7

Table of Contents

• 1. Sultamicillin CAS 76497-13-7: Key Specifications & Comparative Analysis
• 2. Therapeutic Applications & Mechanism of Action
• 3. Clinical Usage Guidelines & Administration Protocols
• 4. Clinical Efficacy Case Studies
• 5. Verified Client Utilization Scenarios
• 6. Request Professional Consultation

1. Sultamicillin CAS 76497-13-7: Key Specifications & Comparative Analysis

Chemical Profile

Comparative Analysis Table

2. Therapeutic Applications & Mechanism of Action

Primary Clinical Indications

• Respiratory tract infections (Community-acquired pneumonia)
• Urinary tract infections (Complicated pyelonephritis)
• Skin/soft tissue infections (Diabetic foot infections)
• Intra-abdominal infections (Peritonitis)

Pharmacological Action

The 1:1 molecular combination of sulbactam (β-lactamase inhibitor) and ampicillin (β-lactam antibiotic) demonstrates synergistic bactericidal activity against β-lactamase-producing pathogens.

3. Clinical Usage Guidelines & Administration Protocols

Dosing Recommendations

Contraindications

• Hypersensitivity to penicillin derivatives
• Severe renal impairment (CrCl <30ml/min)

4. Clinical Efficacy Case Studies

Case Study 1: MDR Respiratory Infection

A 2019 multicenter trial demonstrated 92.3% clinical cure rate in β-lactamase-positive Haemophilus influenzae pneumonia using sultamicillin 1g TID regimen.

Case Study 2: Complicated UTI Management

Phase III clinical data showed 87% microbiological eradication in extended-spectrum β-lactamase (ESBL) producing E. coli urinary infections.

5. Verified Client Utilization Scenarios

Client A: Southeast Asian Hospital Network

• Application: Post-surgical infection prophylaxis
• Outcome: 40% reduction in SSI rates
• Regimen: 750mg IV pre-op + 500mg PO BID post-op

Client B: European Infectious Disease Center

• Application: MDR abdominal sepsis protocol
• Outcome: 78% survival rate in ICU patients
• Regimen: 1.5g IV TID + targeted antifungals

6. Request Professional Consultation

Contact our antimicrobial specialists for formulation optimization, regulatory support, and clinical protocol development:

Email: info@vivalr.com
Tel: (86) 15866781826